Literature DB >> 7551971

The role of vasoactive mediators in portal hypertension.

J C García-Pagán1, J Bosch, J Rodés.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7551971

Source DB:  PubMed          Journal:  Semin Gastrointest Dis        ISSN: 1049-5118


× No keyword cloud information.
  10 in total

Review 1.  Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.

Authors:  J Vlachogiannakos; A K Tang; D Patch; A K Burroughs
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

Review 2.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 3.  Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research.

Authors:  Simon C Ling; Thomas Walters; Patrick J McKiernan; Kathleen B Schwarz; Guadalupe Garcia-Tsao; Benjamin L Shneider
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-03       Impact factor: 2.839

4.  Enhanced expression of endothelin B receptor at protein and gene levels in human cirrhotic liver.

Authors:  H Yokomori; M Oda; Y Yasogawa; Y Nishi; M Ogi; M Takahashi; H Ishii
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

5.  Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis.

Authors:  Tung-Ming Leung; George L Tipoe; Emily C Liong; Thomas Y H Lau; Man-Lung Fung; Amin A Nanji
Journal:  Int J Exp Pathol       Date:  2008-04-21       Impact factor: 1.925

6.  Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats.

Authors:  Yongzhong Wei; Suzanne E Clark; E Matthew Morris; John P Thyfault; Grace M E Uptergrove; Adam T Whaley-Connell; Carlos M Ferrario; James R Sowers; Jamal A Ibdah
Journal:  J Hepatol       Date:  2008-04-22       Impact factor: 25.083

7.  Comparative study of three angiotensin II type 1 receptor antagonists in preventing liver fibrosis in diabetic rats: stereology, histopathology, and electron microscopy.

Authors:  Sare Sipal; Zekai Halici; Ilhami Kiki; Beyzagul Polat; Abdulmecit Albayrak; Fatih Albayrak; Emre Karakus; Selina Aksak; Berna Ozturk; Cemal Gundogdu
Journal:  J Mol Histol       Date:  2012-08-26       Impact factor: 2.611

8.  Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl4.

Authors:  Xiao-Zhong Wang; Li-Juan Zhang; Dan Li; Yue-Hong Huang; Zhi-Xin Chen; Bin Li
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

9.  Pathophysiology of portal hypertension and esophageal varices.

Authors:  Hitoshi Maruyama; Osamu Yokosuka
Journal:  Int J Hepatol       Date:  2012-05-15

10.  Renin-angiotensin system and progression of chronic liver diseases.

Authors:  Hitoshi Yoshiji; Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2006-10       Impact factor: 6.772

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.